Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |